Shows
PharmaSource PodcastBuilding Better CDMO Relationships: ten23 health’s Blueprint for Successful Pharmaceutical Partnerships“My ambition for being a CDMO is that there will always be technical challenges, but I want to be transparent about the challenge and provide options to a customer.”Hanns-Christian Mahler, CEO of ten23 health, brings 15 years of sponsor-side experience to his current role leading a sterile product CDMO focused on drug product development, manufacturing and testing. His unique perspective from both sides of the outsourcing relationship provides valuable insights into building successful partnerships.In the latest PharmaSource podcast episode recorded at CDMO Live 2025, Hanns explains why transparency, realistic planning and early development integration are esse...2025-05-2909 min
PharmaSource PodcastWhat is a Human-Centric CDMO? In conversation with Hanns-Christian Mahler, CEO at ten23 healthHanns-Christian Mahler, Chief Enablement Officer at ten23 health, is redefining leadership in pharmaceutical manufacturing: “I believe collaboration at the workplace should be primarily based on trust and motivation, not on typical carrot and stick command and control models.”
Founded in 2021, ten23 health has a mission to be a human-centric and sustainable strategic partner of the pharmaceutical industry. With extensive experience at companies including Merck, Roche, and Lonza, Hanns-Christian brings a fresh perspective to the CDMO space, combining technical expertise with innovative leadership approaches.
In the latest episode of the PharmaSource podcast, Hanns-Christian shared insights into how t...2024-12-0843 min
Kopf & Herz Hand in HandRaum für Bedürfnisse schaffen, mit Prof. Dr. Hanns-Christian MahlerAufgrund der Krankheit seines Vaters, widmete Prof. Dr. Hanns-Christian Mahler seine ersten Berufsjahre vollkommen der Entwicklung eines Lungenkrebsmedikaments. Nach der Zulassung hat er sich gefragt „Wie weiter?“ Durch weitere berufliche Stationen bei grossen Pharmaunternehmen realisierte er, dass er sich von Cost Center-Strukturen lösen möchte. Dabei hat er seinen eigenen Führungsstil entwickelt und ging Dinge unternehmerischer, menschenzentrierter und nachhaltiger an. Daraus entstand sein Unternehmen ten23 health.
Hanns-Christian beschreibt, wie Holokratie als Organisationsprinzip bei ten23 health funktioniert. Und wir reden über Personalentwicklung in holokratischen Strukturen. Hanns-Christian zeigt auf, dass es um mehr geht, als eine Beförderung, einen neuen Titel ode...2024-09-2431 min
The Brightroom PodcastE4 - Beyond The Carrot And Stick (with ten23 health)Wondering if there’s a better way to do performance appraisals than the forced distribution of the bell curve? Hanns-Christian Mahler and Felicia Werk from ten23 health are sharing human-centric strategies for genuine growth and accountability. ten23 health is based on new work and hashtag holocracy principles and is dedicated to pursuing more adaptive and meaningful ways of working. We dive deep into what’s wrong with traditional performance management practices and explore innovative, human-centric approaches that go beyond the “carrot and stick” methods. How to craft a holistic performa...2024-08-191h 22
Drug SolutionsGrowth and Advancements in Fill/FinishIn this episode of the Drug Solutions podcast, Felicity Thomas, Associate Editorial Director, chats with Hanns-Christian Mahler, CEO and board member of ten23 health, about the growing demand for fill/finish services, technological advances and novel approaches helping to advance fill/finish, sustainable and green practices, the impact of smaller batch sizes, and regulatory guidance updates in the space.
SPONSORS: Vetter2024-06-2519 min
People-Powered SolutionsRevolutionizing Organizational Dynamics with Hanns-Christian MahlerIn this episode, Lori interviews Hanns-Christian Mahler, CEO of ten23 Health, about their unique approach to organizational culture. They discuss the importance of trust, autonomy, and creating a psychologically safe environment. Hanns-Christian shares insights from the Loop Approach and how it has shaped their organization's structure and decision-making processes. They also emphasize the need to question the status quo and take ownership of personal development. Key highlights: Finding your internal purpose The Loop Approach Creating a psychologically safe environment Questioning the status quo and redefining controls Taking ownership of your own development Connect w...2024-03-1244 min
How to New Work019 | Selbstorganisation in der Pharma-BrancheIn dieser Folge ist Hanns-Christian, Gründer und CEO (oder auch "Aussenminister", wie er sich in seiner Rolle nennt) von ten23 health zu Gast.
Er hat das Pharma- und Biotech-Startup vor 2.5 Jahren nach dem Loop-Approach aufgebaut. Das heisst selbstorganisiert und nach stärkenbasierten Rollen und Verantwortlichkeiten. Doch was heisst das nun konkret?
Wir sprechen darüber:
wieso sich Hanns-Christian für diesen Ansatz entschieden hat
worin er den Mehrwert und Herausforderungen sieht
was es mit seiner Rolle als "Aussenminister" auf sich hat
wieso es sich lohnt von Anfang an auf Kultur und Haltung zu setz...2024-01-3040 minHow to New Work019 | Selbstorganisation in der Pharma-BrancheIn dieser Folge ist Hanns-Christian, Gründer und CEO (oder auch "Aussenminister", wie er sich in seiner Rolle nennt) von ten23 health zu Gast.
Er hat das Pharma- und Biotech-Startup vor 2.5 Jahren nach dem Loop-Approach aufgebaut. Das heisst selbstorganisiert und nach stärkenbasierten Rollen und Verantwortlichkeiten. Doch was heisst das nun konkret?
Wir sprechen darüber:
wieso sich Hanns-Christian für diesen Ansatz entschieden hat
worin er den Mehrwert und Herausforderungen sieht
was es mit seiner Rolle als "Aussenminister" auf sich hat
wieso es sich lohnt von Anfang an auf Kultur und Haltung zu setz...2024-01-3040 min
Leverage Business! - Das nachhaltig wachsende Unternehmen im MittelstandInterview mit Hanns-Christian Mahler, Geschäftsführer der @ten23 health #52Uwe Techt kooperiert mit seiner Firma, der VISTEM, seit über 20 Jahren mit Mittelstandsunternehmen in den verschiedensten Branchen und möchte Ihnen mit diesem Podcast Ideen, Geschichten, Strategien und Werkzeuge an die Hand geben, damit Sie den einen Hebel in Ihrem Unternehmen finden, der nachhaltiges Wachstum ermöglicht.
In dieser Episode spricht Uwe Techt, VISTEM, mit Hanns-Christian Mahler, Geschäftsführer @ten23 health und es geht um Themen wie
➡️ Warum Kapazität und Auslastung in der Pharmaindustrie eine so große Rolle spielt
➡️ Wertschöpfungsketten und Spezialisierungen als Dienstleister für große und kleine U...2023-10-3047 min
Life Science SuccessHanns-Christian Mahler - Founder, CEO, and Board Member of ten23 health AGSend us a textIn this episode of Life Science Success, my guest is Hanns-Christian Mahler. Dr. Mahler is Founder, CEO and Board Member at Ten23 health AG, the human-centric and sustainable pharmaceutical development partner. Hanns-Christian Mahler is the Founder, CEO, and Board Member of ten23 health AG, a company specializing in sustainable pharmaceutical development. He has a background in pharmacy and has worked in various pharmaceutical companies and CDMOs (Contract Development and Manufacturing Organizations). Mahler's leadership style focuses on building organizations from the ground up, emphasizing the importance of values, pu...2023-09-0335 min
Drug SolutionsConsidering Biologic Drug Development and Manufacturing HolisticallyIn this episode of the Drug Solutions podcast, Felicity Thomas, European/Senior Editor, talks to Hanns-Christian Mahler, CEO and board member, and Andrea Allmendinger, chief scientific officer, both at ten23 health about some of the hurdles facing developers and manufacturers of biological therapies. Hanns-Christian and Andrea take a closer look at some of the solutions being used within industry to overcome these challenges and focus on the issue of sustainability within this sphere. Finally, they touch upon some of the other potentially important future trends that will impact biologic drug development and manufacturing.2023-05-0222 min
Molecule to Market: Inside the outsourcing spaceChronicles of Swiss Biotech day
Event season is truly well on its way and where better to start than Swiss Biotech Day, the leading biotechnology conference in Switzerland. Renowned for its innovative biotech start-ups and big pharma companies all in attendance, it was a great chance to meet experts from the life science industry from across Europe. Which is why it should come as no surprise that your host Raman Sehgal brought Molecule to market once more to the event space.
If you loved the ‘Memoir of DCAT 2022’ episode, this is a pod for you as he hit the...2022-05-1126 min
Drug SolutionsDrug Manufacturing TechnologyIn this episode of the Drug Solutions podcast, Felicity Thomas, European Editor, talks to a panel of experts on drug dosage forms trends that have been impactful in recent years and those that may have an impact in the future. Some talking points include recent overarching dosage form developments, the value and importance of patient-centricity, and the potential effect of novel excipients. The panel of experts involved in this discussion were Anita Solanki and Dr. Jnanadeva Bhat, both from ACG Group; Cornell Stamoran, from the Catalent Applied Drug Delivery Institute; Dr. Ali Rajabi-Siahboomi from Colorcon; Brad Gold, from Metrics Contract...2022-04-0119 min
Drug SolutionsDrug Dosage Form TrendsIn this episode of the Drug Solutions podcast, Felicity Thomas, European Editor, talks to a panel of experts on drug dosage forms trends that have been impactful in recent years and those that may have an impact in the future. Some talking points include recent overarching dosage form developments, the value and importance of patient-centricity, and the potential effect of novel excipients. The panel of experts involved in this discussion were Aneeta Solanki and Dr Jnanadeva Bhat, both from ACG Group; Cornell Stamoran, from the Catalent Applied Drug Delivery Institute; Dr Ali Rajabi-Siahboomi from Colorcon; Brad Gold, from Metrics Contract...2022-03-1549 minMolecule to Market: Inside the outsourcing spaceFrom corporate rebel to CDMO entrepreneur
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Hanns-Christian Mahler CEO at ten23 health.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Hanns, covering:
Transitioning from the structure and scale of Merck, Roche and Lonza into an entrepreneurial start-up CDMO leader.
Having a business purpose focused on the triple-bottom line that is not just profit - patients, people and planet.
Tips and insights of how a CDMO can play its part in encouraging su...2022-02-2550 min
Academia de Clarinete el podcast52. Entrevista a Darío MariñoSi en 17 minutos pudiera mostrarte cómo mejorar la velocidad (y calidad) de tu articulación en los próximos 30 días o menos… ¿te interesaría saber cómo?
Regístrate aquí y Accede Ahora a esta Clase Gratuita para descubrir cómo mejorar tu articulación
En el episodio de hoy tenemos como invitado a Darío Mariño, Clarinete Solista de la Orquesta Sinfónica del Gran Teatro del Liceo de Barcelona.
Darío inició sus estudios con el clarinete en Galicia y más adelante decidió continuar con su formación en Berlín...2021-09-0352 minAcademia de Clarinete el podcast52. Entrevista a Darío MariñoSi en 17 minutos pudiera mostrarte cómo mejorar la velocidad (y calidad) de tu articulación en los próximos 30 días o menos… ¿te interesaría saber cómo?
Regístrate aquí y Accede Ahora a esta Clase Gratuita para descubrir cómo mejorar tu articulación
En el episodio de hoy tenemos como invitado a Darío Mariño, Clarinete Solista de la Orquesta Sinfónica del Gran Teatro del Liceo de Barcelona.
Darío inició sus estudios con el clarinete en Galicia y más adelante decidió continuar con su formación en Berlín...2021-09-0352 min